Michael Goldberg has served as a member and chairman of our board of directors since November 2011. From January 2005 to May 2011, Mr. Goldberg was a partner at Mohr Davidow Ventures, a venture capital firm, where he led life sciences investments in the area of molecular diagnostics, personalized medicine, and wireless healthcare. From October 2000 to December 2004, Mr. Goldberg operated a management and financial consultancy business. In 1995, Mr. Goldberg founded OnCare, Inc., an oncology disease management company, and served as chairman until August 2001 and as chief executive officer until March 1999. In 1987, Mr. Goldberg founded Axion, Inc., a cancer treatment services company, and served as chief executive officer until its sale to Bristol-Myers Squibb in 1995. Prior to Axion, Mr. Goldberg was a partner at the venture capital firm, Sevin Rosen Management Company, from 1985 to 1987, where he established the firm’s life science practice, and was director of corporate development at Cetus Corporation from 1981 to 1985. Mr. Goldberg has served as a member of the board of directors of numerous companies in the biotech and health sciences industry, and currently serves as executive chairman of DNAnexus, Inc. Mr. Goldberg has served on boards and advisory boards of a number of industry, academic, and public policy institutions in biotechnology and finance, including the board of the Independent Citizens Oversight Committee, which is the governing board for the California Institute for Regenerative Medicine, the board of the Western Association of Venture Capitalists, the advisory boards of the Harvard Center for Genetics and Genomics, the Berkeley Center for Law and Technology, and the UCSF Center for Translational and Policy Research on Personalized Medicine. Mr. Goldberg holds a BA from Brandeis University and an MBA from the Stanford Graduate School of Business.
What is Michael D. Goldberg's net worth?
The estimated net worth of Michael D. Goldberg is at least $508,721.39 as of April 11th, 2022. Mr. Goldberg owns 62,267 shares of CareDx stock worth more than $508,721 as of April 22nd. This net worth estimate does not reflect any other investments that Mr. Goldberg may own. Learn More about Michael D. Goldberg's net worth.
How do I contact Michael D. Goldberg?
Has Michael D. Goldberg been buying or selling shares of CareDx?
Michael D. Goldberg has not been actively trading shares of CareDx during the last quarter. Most recently, Michael Goldberg sold 500 shares of the business's stock in a transaction on Monday, April 11th. The shares were sold at an average price of $36.01, for a transaction totalling $18,005.00. Following the completion of the sale, the director now directly owns 62,267 shares of the company's stock, valued at $2,242,234.67. Learn More on Michael D. Goldberg's trading history.
Who are CareDx's active insiders?
CareDx's insider roster includes Paul Adler (CEO), George Bickerstaff, III (Director), Ankur Dhingra (CFO), Michael Goldberg (Director), William Hagstrom (Director), Sasha King (CMO), Peter Maag (Insider), Reginald Seeto (Insider), Ralph Snyderman (Director), and Thomas Thomas (Director). Learn More on CareDx's active insiders.
Are insiders buying or selling shares of CareDx?
In the last twelve months, insiders at the sold shares 11 times. They sold a total of 44,448 shares worth more than $405,276.89. The most recent insider tranaction occured on October, 2nd when insider Reginald Seeto sold 2,818 shares worth more than $19,472.38. Insiders at CareDx own 4.2% of the company.
Learn More about insider trades at CareDx. Information on this page was last updated on 10/2/2023.
